Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M2MR
|
||||
Former ID |
DAP000522
|
||||
Drug Name |
Gliclazide
|
||||
Synonyms |
Diaikron; Diamicron; Gliclazida; Gliclazidum; Gliklazid; Glimicron; Glyclazide; Nordialex; S 1702; S 852; SE 1702; Diamicron (TN); Dianorm (TN); Gliclazida [INN-Spanish]; Gliclazidum [INN-Latin]; Glimicron (TN); S-1702; S-852; Gliclazide (JAN/INN); Glubitor-OD (TN); Gliclazide [BAN:INN:DCF:JAN]; N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide; N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide; N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea; 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Approved | [549819] | ||
Therapeutic Class |
Hypoglycemic Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H21N3O3S
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
|
||||
InChI |
1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)
|
||||
InChIKey |
BOVGTQGAOIONJV-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 21187-98-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
3206372, 5035155, 7848662, 7979407, 8152209, 10321809, 11342141, 11362324, 11364372, 11366934, 11369496, 11372903, 11374235, 11377658, 11466586, 11467706, 11486292, 11487726, 11491677, 11492413, 11495292, 11533945, 14826273, 24895090, 26612635, 26612723, 26748918, 26748919, 26748920, 29222608, 47656599, 47730748, 48179242, 48179243, 48328563, 48403959, 48416054, 49646130, 49698833, 50061218, 50086570, 50107481, 50107482, 50107483, 50880518, 57321824, 81040947, 81066070, 81093129, 85280584
|
||||
ChEBI ID |
ChEBI:31654
|
||||
SuperDrug ATC ID |
A10BB09
|
||||
SuperDrug CAS ID |
cas=021187984
|
||||
Target and Pathway | |||||
Target(s) | Sulfonylurea receptor 1 | Target Info | Blocker | [535269], [535457] | |
Pathway Interaction Database | FOXA2 and FOXA3 transcription factor networks | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Pancreas Function | |||||
WikiPathways | Potassium Channels | ||||
Integration of energy metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.